АЛКОГОЛЬНАЯ БОЛЕЗНЬ ПЕЧЕНИ – КЛЮЧЕВЫЕ ВОПРОСЫ ЭПИДЕМИОЛОГИИ И ПАТОГЕНЕЗА ЗАБОЛЕВАНИЯ
Основное содержимое статьи
Аннотация
Цель исследования – провести аналитический обзор современных источников научной литературы, освещающих вопросы патогенеза алкогольной болезни печени.
Материалы и методы. Проведен анализ 55 отечественных и зарубежных источников литературы по данной теме.
Результаты. По результатам анализа научных данных обновлено представление о патогенезе алкогольной болезни печени.
Заключение. Алкогольная болезнь печени ассоциирована с ближайшими и отдаленными фатальными рисками, что делает ее актуальной проблемой. Проведенный анализ свидетельствует, что данная патология требует дальнейшего изучения.
Ключевые слова
Информация о статье
Информация о финансировании и конфликте интересов
Авторы заявляют об отсутствии явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Контент доступен под лицензией Creative Commons Attribution 4.0 License.
Как цитировать
Список литературы
Mathurin P, Hadengue A, Bataller R. EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. European Association for the Study of the Liver. J of Hepatology. 2012; 57: 399-420
Jürgen Rehm. The risks associated with alcohol use and alcoholism. Alcohol Res Health. 2011; 34(2): 135-143
Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014; 12: 145
Sheron N. Alcohol and liver disease in Europe: simple measures have the potential to prevent tens of thousands of premature deaths. J Hepatol. 2016; 64: 957-967
Axley PD, Richardson CT, Singal AK. Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. Clin Liver Dis. 2019; 23(1): 39-50
Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, et al. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol. 2017; 46: 827-839
Rehm J, Room R, Graham K, et al. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: An overview. Addiction. 2003; 98(9): 1209-1228
Mackenbach JP, Kulhánová I, Bopp M, Borrell C, Deboosere P, Kovács K et al. Inequalities in Alcohol-Related Mortality in 17 European Countries: A Retrospective Analysis of Mortality Registers. PLoS Med. 2015; 12(12): e1001909
Indicator Code Book Global Information System on Alcohol and Health. WHO, 2016
Russian statistical yearbook. 2019: Statsb./Rosstat. P76 M., 2019; 708 p. Russian (Российский статистический ежегодник. 2019: Стат.сб./Росстат. Р76 М., 2019. 708 с.)
Stickel F, Datz C, Hampe J, Bataller R. Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver. 2017; 11(3): 447
2015-2020 Dietary Guidelines for Americans. In: 8th ed. U.S. Department of Health and Human Services and U.S. Department of Agriculture; 2015
WHO. Food based dietary guidelines. 2003
Patra J, Taylor B, Rehm J. Deaths associated with high-volume drinking of alcohol among adults in Canada in 2002: A need for primary care intervention? Contemporary Drug Problems. 2009; 36(2): 283-301
Shield KDR, Rehm, J. Public health successes and missed opportunities Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990–2014. In. WHO. Copenhagen, Denmark: WHO Regional Office for Europe; 2016
Becker U, Grønbaek M, Johansen D, et al. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology. 2002; 35: 868-875
Kennedy OJ, Roderick P, Buchanan R, et al. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther. 2016; 43: 562-574
Dam MK, Flensborg-Madsen T, Eliasen M et al. Smoking and risk of liver cirrhosis: a population-based cohort study. Scand J Gastroenterol. 2013; 48: 585-591
Shoreibah M, Anand BS, Singal AK. Alcoholic hepatitis and concomitant hepatitis C virus infection. World J Gastroenterol. 2014; 20: 11929-11934
Hart CL, Morrison DS, Batty GD, et al. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ. 2010; 340: c1240
Reed T, Page WF, Viken RJ, et al. Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res. 1996; 20: 1528-1533
Eagon PK. Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol. 2010; 16: 1377-1384
Baraona E, Abittan CS, Dohmen K, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001; 25: 502-507
Moses VG. Hormonal contraception in women at risk for the development of arterial and venous thrombosis. Questions of gynecology, obstetrics and perinatology. 2009; 2: 83-87. Russian (Мозес В.Г. Гормональная контрацепция у женщин группы риска по развитию артериальных и венозных тромбозов //Вопросы гинекологии, акушерства и перинатологии. 2009. Т. 8, № 2. С. 83-87)
Prince M, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002; 123(4): 1044-1051
Buch S, Stickel F, Trépo E, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015; 47: 1443-1448
Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol. 2017; 66: 195-211
Rocco A, Compare D, Angrisani D. et al. Alcoholic disease: liver and beyond. World J Gastroenterol. 2014; 20(40): 14652-14659
Teschke R. Microsomal ethanol-oxidizing system (MEOS): Success over 50 years and an encouraging future. Alcohol Clin. Exp. Res. 2019; 43: 386-400
Teschke R., Zhu Y. Opinion: Intestinal microbiome, endotoxins, cytochrome P450 2E1, and the gut-liver axis in alcoholic liver disease. EC Gastroenterology Dig. Syst. 2019; 6: 66-75
Salaspuro M. Epidemiological aspects of alcohol and alcoholic liver disease, ethanol metabolism, and pathogenesis of alcoholic liver injury. Oxf. Textb. Clin. Hepatol. 1991; 2: 791-810
Pizon A.F., Becker C.E., Bikin D. The clinical variations in ethanol toxicokinetics. Toxicol Rev. 2007; 3: 63-72
Teschke R. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): Cascade of events, clinical aspects, and pharmacotherapy options. Expert Opin. Pharm. 2018; 19: 779-793
Parker R., Kim SJ., Gao B. Alcohol, adipose tissue and liver disease: Mechanistic links and clinical considerations. Nat. Rev. Gastroenterol. Hepatol. 2018; 15: 50-59
Cederbaum AI. Alcohol metabolism. Clin. Liver Dis. 2012; 16: 667-685
Geschke R., Hasumura Y., Joly J.G., et al. Microsomal ethanol-oxidizing system (MEOS): Purification and properties of a rat liver system free of catalase and alcohol dehydrogenase. Biochem. Biophys. Res. Commun. 1972; 49: 1187-1193
Lieber CS., DeCarli LM. Reduced nicotinamide-adenine dinucleotide phosphate oxidase: Enhanced by ethanol consumption. Science. 1970; 170: 78-80
Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol. 2009; 76(2): 215-228
Teschke R. Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance. Biomedicines. 2019; 7(3): 68
Lieber C.S. Alcohol and the liver: 1994 update. Gastroenterology. 1994; 106: 1085-1105
Rehm J, Taylor B, Mohapatra S, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010; 29: 437-445
Osna NA, Donohue TM, Kharbanda KK. Alcoholic liver disease: Pathogenesis and current management. Alcohol Res. 2017; 38: 147-161
Neuman MG, French SW, Zakhari S, et al. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp. Mol. Pathol. 2017; 102: 162-180
Lieber CS, DeCarli LM, Matsuzaki S, Ohnishi K, Teschke R. The microsomal ethanol oxidizing system (MEOS). Methods Enzym. 1978; 52: 355-367
Brunt EM, Neuschwander-Tetri BA, Burt AD. Fatty liver disease: alcoholic and non-alcoholic. In: Burt A, Portmann B, Ferrell L, editors. MacSween’s pathology of the liver. 6th ed. Edinburgh: Churchill Livingstone, 2012. P. 293-360
Roh YS, Zhang B, Loomba R, Seki E. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol. 2015; 309: 30-41
An L, Wang X, Cederbaum AI. Cytokines in alcoholic liver disease. Arch Toxicol. 2012; 86: 1337-1348
Petrasek J, Csak T, Szabo G. Toll-like receptors in liver disease. Adv Clin Chem. 2013; 59: 155-201
Dubuquoy L, Louvet A, Lassailly G, Truant S, Boleslawski E, Artru F, et al. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut. 2015; 64: 1949-1960
Lanthier N, Rubbia-Brandt L, Lin-Marq N, et al. Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis. J Hepatol. 2015; 63: 609-621
Sancho-Bru P, Altamirano J, Rodrigo-Torres D, et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology. 2012; 55: 1931-1941
Schuppan D. Liver fibrosis: common mechanisms and antifibrotic therapies. Clin Res Hepatol Gastroenterol. 2015; 39: 51-59
Patsenker E, Stoll M, Millonig G, et al. Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Mol Med. 2011; 17: 1285-1294
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127: 35-50
Villanueva A, Portela A, Sayols S, et al. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Hepatology. 2015; 61: 1945-1956